Cleveland, OH, United States of America

Steven J Czinn

This inventor holds 1 USPTO granted patent. Top assignee: Oravax, Inc.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven J Czinn. Retrieved from https://idiyas.com/inventor/steven-j-czinn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Steven J. Czinn

Introduction

Steven J. Czinn is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical science, particularly in the treatment of Helicobacter infections. His innovative approach has led to the development of a unique method that aims to elicit a protective immune response in mammalian hosts.

Latest Patents

Czinn holds a patent for an oral treatment of Helicobacter infection. The patent, titled "Method of eliciting in a mammalian host a protective immune response to Helicobacter infection," involves orally administering an immunogenically effective amount of Helicobacter antigen. This method not only addresses the infection but also provides vaccine compositions that enhance the immune response.

Career Highlights

Czinn is currently associated with Oravax, Inc., where he continues to work on innovative solutions in the medical field. His expertise and dedication have positioned him as a key figure in the development of treatments for bacterial infections.

Collaborations

One of his notable collaborators is John G. Nedrud, with whom he has worked closely to advance their research and innovations in the field.

Conclusion

Steven J. Czinn's contributions to medical science through his innovative patent and collaboration with esteemed colleagues highlight his commitment to improving health outcomes. His work continues to pave the way for advancements in the treatment of Helicobacter infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…